Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.
Conditions: Prostate Cancer; Benign Prostatic Hypertrophy; Bladder Stones; Kidney Stones Intervention: Diagnostic Test: NV-VPAC1 PCa Urine Diagnostic Test Sponsors: Intermountain Health Care, Inc.; NuView Diagnostics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bladder Cancer | Cancer | Cancer & Oncology | Kidney Stones | Prostate Cancer | Urology & Nephrology